We are live on ! Find out more

14 hedge funds and large institutions have $691K invested in DNA X in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

17% more capital inflows, than outflows

Capital inflows: $119K | Capital outflows: $102K

8% more funds holding

Funds holding: 13 → 14 (+1)

0.04% more ownership

Funds ownership: 1.64% → 1.68% (+0.04%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

SONM Hedge Fund Activity: Q1 2023 in Review

14 of the 6,291 institutional investors tracked by Wall St. Rank reported a position in DNA X (SONM) for Q1 2023, worth a combined $691K — up 143% from $284K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new SONM positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Sicart Associates, opening a new position worth an estimated $104K. The largest seller was Millennium Management, cutting an estimated $57.1K.

  • 14 institutional investors held DNA X (SONM) as of Q1 2023, up from 13 in Q4 2022.
  • Funds reported $691K of DNA X stock for Q1 2023, up 143% quarter-over-quarter.
  • 4 funds opened new DNA X positions in Q1 2023 and 3 closed out, a net change of +1 holder.
  • The largest DNA X buyer in Q1 2023 was Sicart Associates, an estimated $104K added.
  • The largest DNA X seller in Q1 2023 was Millennium Management, an estimated $57.1K sold.

Based on aggregated 13F filings for Q1 2023.